1. Market Research
  2. > Cancer Industry

Colorectal Cancer Industry, February 2017 Market Reports from Top Publishers

You might be interested in: Cancer, Therapy, Diagnostics, Biopsy, Cancer Diagnostic, Infectious Disease, Endoscope, Cancer Biomarker, Medical Robot, Cancer Immunotherapy, Biomarker, Biosimilar, Molecular Diagnostic, Oncology, Cloud Computing, DNA, Gastric Cancer, Incontinence Product, Pharmaceutical, Point Of Care Testing.


 
1-10 of 48 reports for Colorectal Cancer

Purchase Reports From Reputable Market Research Publishers

Colorectal cancer (mCRC) - Epidemiology Forecast To 2023

Colorectal cancer (mCRC) - Epidemiology Forecast To 2023

  • $ 2750
  • Industry report
  • January 2017
  • by Delve Insight

DelveInsight “Colorectal cancer (mCRC) - Epidemiology Forecast To 2023” provides an overview of the epidemiology trends of Colorectal cancer (mCRC) in seven major markets (US, France, Germany, Italy, ...

Global Colorectal Cancer Partnering 2010 to 2017

Global Colorectal Cancer Partnering 2010 to 2017

  • $ 1495
  • Industry report
  • February 2017
  • by Currentpartnering

Summary Provides understanding and access to the colorectal cancer partnering deals and agreements entered into by the worlds leading healthcare companies . Description The Global Colorectal Cancer Partnering ...

Metastatic Colorectal Cancer-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2017

Metastatic Colorectal Cancer-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2017

  • $ 2000
  • Industry report
  • January 2017
  • by Delve Insight

DelveInsight’s Report, “Metastatic Colorectal Cancer-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2016”, provides comprehensive insights about the marketed drugs, drug sales, ...

Colorectal Cancer-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2017

Colorectal Cancer-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2017

  • $ 2000
  • Industry report
  • January 2017
  • by Delve Insight

DelveInsight’s Report, “Colorectal Cancer-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2016”, provides comprehensive insights about the marketed drugs, drug sales, Phase III ...

Colorectal cancer (mCRC)- Market Insights, Epidemiology and Market Forecast-2023

Colorectal cancer (mCRC)- Market Insights, Epidemiology and Market Forecast-2023

  • $ 4950
  • Industry report
  • January 2017
  • by Delve Insight

Note*: This report requires 5 business days to complete. DelveInsight’s Colorectal cancer (mCRC - Market Insights, Epidemiology and Market Forecast-2023” Reports provides an overview of the disease ...

Colorectal Cancer - Pipeline Review, H2 2016

Colorectal Cancer - Pipeline Review, H2 2016

  • $ 2500
  • Company report
  • December 2016
  • by Global Markets Direct

Colorectal Cancer - Pipeline Review, H2 2016 Summary Global Markets Direct’s latest Pharmaceutical and Healthcare disease pipeline guide Colorectal Cancer – Pipeline Review, H2 2016, provides an overview ...

EpiCast Report: Colorectal Cancer - Epidemiology Forecast to 2025

EpiCast Report: Colorectal Cancer - Epidemiology Forecast to 2025

  • $ 3995
  • Industry report
  • December 2016
  • by Global Data

EpiCast Report: Colorectal Cancer - Epidemiology Forecast to 2025 Summary Colorectal cancer (CRC) is a cancer that starts in the colon or the rectum (ACS, 2016). CRC is one of the most common types of ...

Global Colorectal Cancer Diagnostics & Therapeutics Market

Global Colorectal Cancer Diagnostics & Therapeutics Market

  • $ 4250
  • Industry report
  • December 2016
  • by Mordor Intelligence LLP

The global colorectal cancer diagnostics and therapeutics market is expected to grow at a CAGR of around 6% during the forecast period 2016-2021. The market is estimated to be valued at USD 8000 million ...

Metastatic Colorectal Cancer - Pipeline Review, H2 2016

Metastatic Colorectal Cancer - Pipeline Review, H2 2016

  • $ 2000
  • Company report
  • November 2016
  • by Global Markets Direct

Metastatic Colorectal Cancer - Pipeline Review, H2 2016 Summary Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Metastatic Colorectal Cancer – Pipeline Review, H2 ...

Colorectal Cancer KOL Insight 2016

Colorectal Cancer KOL Insight 2016

  • $ 8085
  • Industry report
  • October 2016
  • by Firstword Pharma

KOLs embrace novel MoAs as low survival rates drive search for new treatments Faced with persistently low survival rates, KOLs are calling for new approaches to treat late-stage colorectal cancer (CRC). ...

About 5800 reports for Colorectal Cancer

Download Unlimited Documents from Trusted Public Sources

Colorectal Cancer Statistics in the US

  • October 2015
    240 pages
  • Colorectal Canc...  

    Computed Tomogr...  

  • United States  

View report >

Reportlinker.com © Copyright 2017. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.